E-LIB Suche - Ergebnisse für: Narejos Pérez, Sílvia

1

Respiratory Syncytial Virus Disease Burden in Community-Dwe..:

Narejos Pérez, Sílvia ; Ramón Torrell, Josep María ; Põder, Airi...
Open Forum Infectious Diseases. 10 (2023) 4 - p. , 2023

Link: https://doi.org/10.1093/..

2

A phase 3 trial of safety, tolerability, and immunogenicity..:

Platt, Heather L. ; Cardona, Jose F. ; Haranaka, Miwa...
Vaccine. 40 (2022) 1 - p. 162-172 , 2022

Link: https://doi.org/10.1016/..

3

Telemedicine in the face of the COVID-19 pandemic:

Vidal-Alaball, Josep ; Acosta-Roja, Ruthy ; Pastor Hernández, Nuria...
Atención Primaria. 52 (2020) 6 - p. 418-422 , 2020

Link: https://doi.org/10.1016/..

4

Immunogenicity, reactogenicity and safety of an inactivated..:

Kieninger, Dorothee ; Sheldon, Eric ; Lin, Wen-Yuan...
BMC Infectious Diseases. 13 (2013) 1 - p. , 2013

Link: https://doi.org/10.1186/..

5

The respiratory syncytial virus prefusion F protein vaccine..:

Curran, Desmond ; Matthews, Sean ; Cabrera, Eliazar Sabater...
Influenza and Other Respiratory Viruses. 18 (2024) 2 - p. , 2024

Link: https://doi.org/10.1111/..

6

Respiratory Syncytial Virus Disease Burden in Community-Dwe..:

Narejos Pérez, Sílvia ; Ramón Torrell, Josep María ; Põder, Airi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10099469/. , 2023

Link: http://www.ncbi.nlm.nih...

7

Respiratory Syncytial Virus Disease Burden in Community-Dwe..:

Narejos Pérez, Sílvia ; Ramon Torrell, Josep M. (Josep Maria) ; Põder, Airi...
Reproducció del document publicat a: https://doi.org/10.1093/ofid/ofad111. , 2023

Link: http://hdl.handle.net/24..

8

Telemedicine in the face of the COVID-19 pandemic ; Telemed..:

Vidal Alaball, Josep ; Acosta Roja, Ruthy ; Pastor Hernández, Nuria...
0212-6567. , 2020

Link: http://hdl.handle.net/10..

9

Safety profile of the adjuvanted recombinant zoster vaccine..:

Lopez-Fauqued, Marta ; Campora, Laura ; Delannois, Frederique...
Vaccine, 0264-410X, 2019, 37:18, s. 2482-2493. , 2019

Link: http://urn.kb.se/resolve..

10

Immunogenicity, reactogenicity and safety of an inactivated..:

Kieninger, Dorothee ; Sheldon, Eric ; Lin, Wen-Yuan...
http://www.biomedcentral.com/1471-2334/13/343. , 2013

Link: http://www.biomedcentral..

11

Telemedicine in the face of the COVID-19 pandemic:

Vidal Alaball, Josep ; Acosta Rojas, Emilia Ruthy ; Pastor Hernández, Nuria...
Aten Primaria. 2020 Jun-Jul;52(6):418-422. ,

Link: http://hdl.handle.net/10..

12

Validación clínica de 2 agrupadores de morbilidad en el ámb..:

Montse Clèries ; David Monterde ; Emili Vela...
http://www.sciencedirect.com/science/article/pii/S0212656718302142. , 2020

Link: https://doi.org/10.1016/..

13

Telemedicine in the face of the COVID-19 pandemic:

Josep Vidal-Alaball ; Ruthy Acosta-Roja ; Nuria Pastor Hernández...
http://www.sciencedirect.com/science/article/pii/S0212656720301268. , 2020

Link: https://doi.org/10.1016/..

14

Safety profile of the adjuvanted recombinant zoster vaccine..:

López Fauqued, Marta ; Campora, Laura ; Delannois, Frédérique...
Vaccine. , 2019

Link: https://ddd.uab.cat/reco..

15

Model del Programa d'atenció domiciliària (ATDOM) de l'aten..:

Avellí Muñoz, Judit ; Boada, Albert ; Contel-Segura, Joan C...
Avellí Muñoz J, Boada Valmaseda A, Contel Segura JC, Costa Menen À, del Pozo Niubo J, Díaz Álvarez ME, et al. Model del Programa d'atenció domiciliària (ATDOM) de l'atenció primària i comunitària (APiC). Barcelona: Direcció General de Planificació en Salut; 2022.. , 2022

Link: https://hdl.handle.net/1..